Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)

被引：0
|
作者：
Liu, John [1 ]
Coney, Joseph [2 ]
Schartman, Jerome [2 ]
Miller, David G. [2 ]
Zegarra, Hernando [2 ]
Rao, Llewelyn [2 ]
机构：
[1] Case Western Reserve Univ, Ophthalmol, Clevleand, OH USA
[2] Retina Associates Cleveland Inc, Cleveland, OH USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4816
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Diabetic Macular Edema: Intravitreal Fluocinolone Acetonide reduces the Treatment Burden
    Thieme, Eve-Claudia
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2023, 240 (09) : 1040 - +
  • [22] ICE-UK - The evaluation of the fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular edema (DME) in NHS clinical practice
    Collins, Daniela
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [23] Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant
    Ciulla, Thomas A.
    Harris, Alon
    McIntyre, Nathaniel
    Jonescu-Cuypers, Christian
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 953 - 959
  • [24] The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular edema
    Cicinelli, Maria Vittoria
    Rosenblatt, Amir
    Grosso, Domenico
    Zollet, Piero
    Capone, Luigi
    Rabiolo, Alessandro
    Lattanzio, Rosangela
    Loewenstein, Anat
    Bandello, Francesco
    EYE, 2021, 35 (12) : 3232 - 3242
  • [25] Efficacy and safety of corticosteroid implant (Fluocinolone Acetonide (FAc) 0.2 lg/day, Iluvien ®) for management of Diabetic Macular Edema (DME): a real-life study
    Vieira, M.
    Pereira, J.
    Santos, M.
    Arruda, H.
    Sousa, J.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 135 - 136
  • [26] Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema
    Kessler, Lucy Joanne
    Labuz, Grzegorz
    Auffarth, Gerd U.
    Khoramnia, Ramin
    PHARMACEUTICS, 2022, 14 (04)
  • [27] Fluocinolone acetonide (Iluvien) extended-release intravitreal implant for diabetic macular edema
    Carle, Michelle V.
    Chu, Thomas G.
    Boyer, David S.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2014, 9 (02) : 81 - 88
  • [28] Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
    Baillif, Stephanie
    Staccini, Pascal
    Weber, Michel
    Delyfer, Marie-Noelle
    Le Mer, Yannick
    Gualino, Vincent
    Collot, Laurence
    Merite, Pierre-Yves
    Creuzot-Garcher, Catherine
    Kodjikian, Laurent
    Massin, Pascale
    PHARMACEUTICS, 2022, 14 (11)
  • [29] Fluocinolone acetonide intravitreal implant in patients with diabetic macular edema: 12 month results
    Pearson, P
    Baker, CW
    Eliott, D
    Ip, MS
    Morse, LS
    Callanan, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U489 - U489
  • [30] Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy
    Lima-Fontes, Mario
    Leuzinger-Dias, Mariana
    Barros-Pereira, Ricardo
    Fernandes, Vitor
    Falcao, Manuel
    Falcao-Reis, Fernando
    Rocha-Sousa, Amandio
    Alves-Faria, Pedro
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (01) : 377 - 388
12345